You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 251 No. 17, May 4, 1984 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORT
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Sexual Precocity by Removal of a Luteinizing Hormone—Releasing Hormone Secreting Hamartoma

Robert A. Price, MD; Peter A. Lee, MD, PhD; A. Leland Albright, MD; Oline K. Ronnekleiv, PhD; James P. Gutai, MD

JAMA. 1984;251(17):2247-2249.


Abstract

A 1-year-old infant was initially seen with precocious puberty that progressed rapidly and was associated with episodic gonadotropin release. A computed tomographic metrizamide cisternogram showed a pedunculated mass below the tuber cinereum; the mass was resected. His pubertal development regressed, his accelerated growth ceased, and his hormone levels returned to the normal prepubertal range. Immunocytochemical studies of the tissue demonstrated luteinizing hormone—releasing hormone (LHRH) granules in the perikaryon of neurons and axons in the hamartoma and axons connecting the hamartoma to the tuber cinereum. These data suggest that such lesions cause pubertal development by stimulating gonadotropin secretion via episodic release of LHRH. If such lesions are pedunculated, operative resection may be the treatment of choice.

(JAMA 1984;251:2247-2249)



Author Affiliations

From the Departments of Pathology (Dr Price), Pediatrics (Drs Lee and Gutai), Neurosurgery (Dr Albright), and Physiology (Dr Ronnekleiv), University of Pittsburgh, School of Medicine, Children's Hospital of Pittsburgh.


Footnotes

Reprint requests to Division of Pediatric Endocrinology, Children's Hospital of Pittsburgh, 125 DeSoto St, Pittsburgh, PA 15213 (Dr Lee).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Association of Morphological Characteristics with Precocious Puberty and/or Gelastic Seizures in Hypothalamic Hamartoma
Jung et al.
J. Clin. Endocrinol. Metab. 2003;88:4590-4595.
ABSTRACT | FULL TEXT  

Some Hypothalamic Hamartomas Contain Transforming Growth Factor {alpha}, a Puberty-Inducing Growth Factor, But Not Luteinizing Hormone-Releasing Hormone Neurons
J. Clin. Endocrinol. Metab. 1999;84:4695-4701.
ABSTRACT | FULL TEXT  

Hypothalamic Hamartomas and Sexual Precocity: Evaluation of Treatment Options
Starceski et al.
Arch Pediatr Adolesc Med 1990;144:225-228.
ABSTRACT  

Cushing's Disease Associated with an lntrasellar Gangliocytoma Producing Corticotrophin-Releasing Factor
ASA et al.
ANN INTERN MED 1984;101:789-793.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.